38 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Debiopharm Competitors or Alternatives

Debiopharm's top competitors include Melinta, Spero Therapeutics and Tetraphase.

Unlock 14 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Debiopharm's company profile

Bertrand Ducrey

CEO

69/100
250 - 500
$0
$25M - 100M
  • $0
    $25M - 100M
  • 250 - 500
    $0
  • $25M - 100M
  • 69/100
  • 250 - 500
  • $0
  • $25M - 100M
View ProfileView
1
Debiopharm's Competitor - Melinta logo

Christine Ann Miller

President & CEO

88/100
250 - 500
$558.3M
$25M - 100M
  • $558.3M
    $25M - 100M
  • 250 - 500
    $558.3M
  • $25M - 100M
  • 88/100
  • 250 - 500
  • $558.3M
  • $25M - 100M
View ProfileView
2
Debiopharm's Competitor - Spero Therapeutics logo

Sath Shukla

President & CEO

82/100
150
$463.8M
$48M
  • $463.8M
    $48M
  • 150
    $463.8M
  • $48M
  • 82/100
  • 150
  • $463.8M
  • $48M
View ProfileView
3
Debiopharm's Competitor - Tetraphase logo

Larry Edwards

CEO

93/100
25 - 100
$172M
$5M - 25M
  • $172M
    $5M - 25M
  • 25 - 100
    $172M
  • $5M - 25M
  • 93/100
  • 25 - 100
  • $172M
  • $5M - 25M
View ProfileView
4
Debiopharm's Competitor - Achaogen logo

Blake Wise

CEO

77/100
1 - 25
$221.4M
$100K - 5M
  • $221.4M
    $100K - 5M
  • 1 - 25
    $221.4M
  • $100K - 5M
  • 77/100
  • 1 - 25
  • $221.4M
  • $100K - 5M
View ProfileView
5
Debiopharm's Competitor - Prokaryotics logo

Keith Bostian

Interim Co-CEO

88/100
25 - 100
$7.1M
$5M - 25M
  • $7.1M
    $5M - 25M
  • 25 - 100
    $7.1M
  • $5M - 25M
  • 88/100
  • 25 - 100
  • $7.1M
  • $5M - 25M
View ProfileView
Debiopharm's top 17 competitors are Melinta, Spero Therapeutics, Tetraphase, BioCryst, Achaogen, Prokaryotics , Nabriva, Adenium Biotech, Interchem Corporation, Olon, American Antibiotics, Trusted Tablets, VIBATIV, Pear, Forge Therapeutics, Aridis and Your Own Red Carpet Event. Together they have raised over 3.7B between their estimated 3.8K employees. Debiopharm's revenue is the ranked 6th among it's top 10 competitors. The top 10 competitors average 85.9M. Debiopharm has 420 employees and is ranked 3rd among it's top 10 competitors. The top 10 competitors average 265.

Debiopharm VS Melinta

Melinta is Debiopharm's top competitor. Melinta was founded in 2000 in Morristown, New Jersey. Melinta competes in the Biotechnology field. Melinta generates $53.7M more revenue than Debiopharm.

Debiopharm VS Spero Therapeutics

Spero Therapeutics is perceived as one of Debiopharm's biggest rivals. Spero Therapeutics's headquarters is in Cambridge, Massachusetts, and was founded in 2013. Like Debiopharm, Spero Therapeutics also competes in the Pharmaceuticals industry. Spero Therapeutics generates 110% of Debiopharm's revenue.

Debiopharm VS Tetraphase

Tetraphase is one of Debiopharm's top competitors. Tetraphase is a Private company that was founded in Waltham, Massachusetts in 2006. Like Debiopharm, Tetraphase also competes in the Pharmaceuticals field. Tetraphase has 354 fewer employees vs. Debiopharm.

Looking for similar companies to Debiopharm?

Similar Companies

Pharmaceuticals companies in Lausanne

See 11 companies 
Companies in Lausanne with employees in 250-500 range

See 14 companies 
Pharmaceuticals companies in Vaud

See 20 companies 
Companies in Lausanne with revenue in $25-100M range

See 22 companies 
Biotechnology companies in Lausanne

See 38 companies 
Companies in Vaud with employees in 250-500 range

See 41 companies 
Pharmaceuticals & Biotechnology companies in Lausanne

See 49 companies 
Biotechnology companies in Vaud

See 51 companies 
Pharmaceuticals & Biotechnology companies in Vaud

See 71 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Debiopharm and Debiopharm's Competitors

April 16, 2025StreetInsider
RODANO, Italy, April 16, 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. is honored to announce its receipt of the esteemed 2025 CMO Excellence in Green Chemistry...

Frequently Asked Questions about Debiopharm

  1. Who are Debiopharm's top competitors?

    Debiopharm's top 3 competitors are Melinta, Spero Therapeutics, Tetraphase.

  2. Who is similar to Debiopharm?

    Melinta is the most similar to Debiopharm. Spero Therapeutics and Tetraphase are also similar to Debiopharm.

  1. Are Debiopharm and Melinta competitors?

    Yes, Melinta is one of Debiopharm’s top competitors.